Cargando…
Case report: recurrent pituitary adenoma has increased load of somatic variants
BACKGROUND: Pituitary adenomas (PA) have an increased potential for relapse in one to 5 years after resection. In this study, we investigated the genetic differences in genomic DNA of primary and rapidly recurrent tumours in the same patient to explain the causality mechanisms of PA recurrence. CASE...
Autores principales: | Peculis, Raitis, Balcere, Inga, Radovica-Spalvina, Ilze, Konrade, Ilze, Caune, Olivija, Megnis, Kaspars, Rovite, Vita, Stukens, Janis, Nazarovs, Jurijs, Breiksa, Austra, Kiecis, Aigars, Silamikelis, Ivars, Pirags, Valdis, Klovins, Janis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988340/ https://www.ncbi.nlm.nih.gov/pubmed/31996211 http://dx.doi.org/10.1186/s12902-020-0493-x |
Ejemplares similares
-
Evaluation of the Possibility to Detect Circulating Tumor DNA From Pituitary Adenoma
por: Megnis, Kaspars, et al.
Publicado: (2019) -
Whole exome sequencing reveals novel risk genes of pituitary neuroendocrine tumors
por: Peculis, Raitis, et al.
Publicado: (2022) -
Medication for Acromegaly Reduces Expression of MUC16, MACC1 and GRHL2 in Pituitary Neuroendocrine Tumour Tissue
por: Saksis, Rihards, et al.
Publicado: (2021) -
Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue
por: Peculis, Raitis, et al.
Publicado: (2020) -
Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
por: Saksis, Rihards, et al.
Publicado: (2023)